CEU: Literature Review- Treatment of Attention-Deficit/Hyperactivity Disorder
Podrías ser la primera persona en dar tu opinión.
Compre ahora y proporcione su opinión sobre este producto y reciba un crédito de 25 $ en la tienda!
BCBA CEUs: 1- BACB General
QABA CEUs: 1- General
IBAO CEUs: 1- General
APA/CESA: 1 General (Home Study)
Presenter: Dr. Ronald T. Brown conducted a live, video-based Literature Review of Treatment of Attention-Deficit/Hyperactivity Disorder: Overview of the Evidence. This paper was written in collaboration with other distinguished experts Robert W. Amler, MD; Wendy S. Freeman, Ph.D.; James M. Perrin, MD; Martin T. Stein, MD; Heidi M. Feldman, MD, Ph.D.; Karen Pierce, MD; Mark L. Wolraich, MD; and the Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder.
This paper is a review and synthesis of existing literature on Attention-Deficit/Hyperactivity Disorder for the "purpose of developing an evidence-based clinical practice guideline for the treatment of the school-aged child with attention-deficit/hyperactivity disorder (ADHD)." "These reviews provided substantial information about different treatments for ADHD and their efficacy in improving certain characteristics or outcomes for children with ADHD."
TIMELINE: This course, on its own has a license for active use for 30-days unless it is purchased as part of a bundle/library.
MANDATORY DISCLAIMER: The Behavior Analyst Certification Board (“BACB”) does not sponsor, approve, or endorse Special Learning, the materials, information, or sessions identified herein.
NOTE: CEs claimed on any training completed can only be claimed once. If you repeat training you’ve already claimed CEs on, you won’t be able to claim the CEs again. Please ensure you have not already completed and claimed the CEs for the training module before purchase. Want to customize your training? You can build your own CE library HERE. For cancellations and refunds, please see our policy HERE.
Aún no hay opiniones!
Para añadir una opinión sobre este producto es necesario adquirir el producto actual y estar autorizado.